4/A

PRIMARY DOCUMENT

Company: INTEGRATED BIOPHARMA INC
Filed: May 11, 2022
Period of Report: May 6, 2022
Accession Number: 0001053310-22-000002

View Document ↗ View on SEC.gov ↗